MANAGEMENT OF FACIAL PALSY (LAQWA) THROUGH UNANI MEDICINE: A CASE SERIES

Ifra Abdul Qaiyyum, Sameena Abdul Qayyum, M. A. Kalam
{"title":"MANAGEMENT OF FACIAL PALSY (LAQWA) THROUGH UNANI MEDICINE: A CASE SERIES","authors":"Ifra Abdul Qaiyyum, Sameena Abdul Qayyum, M. A. Kalam","doi":"10.53390/ijum.2022.15204","DOIUrl":null,"url":null,"abstract":"Laqwa (facial palsy) is the most common cranial nerve motor neuropathy and it results in a characteristic facial distortion that is determined in part by the nerves branches involved. In majority of cases the cause is idiopathic. Rabban Tabri has originally described facial palsy entitled it as “laqwa” and explained its treatment. Thousands of people each year develop facial paralysis, a relatively common disorder with many different origins (infectious, traumatic, neoplastic, inflammatory, metabolic or idiopathic). The annual incidence has been estimated to be approximately 70 cases per 100,000 populations. Incidence of unilateral facial paralysis is 1,000 cases per 5 million populations per year. Unani scholars from various part of the world have been treating this condition since centuries successfully. Improvement of facial muscle function begins within first 3 weeks after onset of disease. Different effective regimes are available in Unani system of medicine (USM) for the treatment of Laqwa (facial palsy). Those treatments are effective and having fewer side effects. In the present paper the case studies of two male patients suffering from Laqwa (facial palsy). After series of investigation no definitive etiology could be traced out, hence considered as unilateral Facial palsy of left side, treated with Unani formulations is reported. This case series documented the successful treatment and prevention of recurrence of Laqwa (facial palsy) through Unani medicines. It concluded that the Unani regimen was effective and safe in the management of Laqwa (facial palsy).In most cases, Bell's palsy has a good prognosis and the patient will recover with outpatient therapy without complication.","PeriodicalId":13351,"journal":{"name":"Indian Journal of Unani Medicine","volume":"193 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Unani Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53390/ijum.2022.15204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Laqwa (facial palsy) is the most common cranial nerve motor neuropathy and it results in a characteristic facial distortion that is determined in part by the nerves branches involved. In majority of cases the cause is idiopathic. Rabban Tabri has originally described facial palsy entitled it as “laqwa” and explained its treatment. Thousands of people each year develop facial paralysis, a relatively common disorder with many different origins (infectious, traumatic, neoplastic, inflammatory, metabolic or idiopathic). The annual incidence has been estimated to be approximately 70 cases per 100,000 populations. Incidence of unilateral facial paralysis is 1,000 cases per 5 million populations per year. Unani scholars from various part of the world have been treating this condition since centuries successfully. Improvement of facial muscle function begins within first 3 weeks after onset of disease. Different effective regimes are available in Unani system of medicine (USM) for the treatment of Laqwa (facial palsy). Those treatments are effective and having fewer side effects. In the present paper the case studies of two male patients suffering from Laqwa (facial palsy). After series of investigation no definitive etiology could be traced out, hence considered as unilateral Facial palsy of left side, treated with Unani formulations is reported. This case series documented the successful treatment and prevention of recurrence of Laqwa (facial palsy) through Unani medicines. It concluded that the Unani regimen was effective and safe in the management of Laqwa (facial palsy).In most cases, Bell's palsy has a good prognosis and the patient will recover with outpatient therapy without complication.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过unani药物治疗面瘫(laqwa):病例系列
Laqwa(面瘫)是最常见的颅神经运动神经病,它导致特征性的面部扭曲,部分是由所涉及的神经分支决定的。在大多数情况下,病因是特发性的。Rabban Tabri最初将面瘫称为“laqwa”,并解释了其治疗方法。每年有成千上万的人患上面瘫,这是一种相对常见的疾病,有许多不同的病因(感染性、外伤性、肿瘤性、炎症性、代谢性或特发性)。据估计,年发病率约为每10万人70例。单侧面瘫的发病率为每年每500万人中1000例。几个世纪以来,世界各地的Unani学者一直在成功地治疗这种疾病。面部肌肉功能的改善始于发病后的前3周。在乌纳尼医学系统(USM)中,有不同的治疗面部麻痹的有效方法。这些治疗方法有效且副作用少。本文对两例男性面瘫患者进行了病例分析。经过一系列的调查,没有明确的病因可以追查,因此认为是单侧面瘫左侧,用Unani配方治疗的报道。本病例系列记录了通过Unani药物成功治疗和预防Laqwa(面瘫)复发的情况。结论:Unani方案在治疗Laqwa(面瘫)方面是有效和安全的。在大多数情况下,贝尔麻痹预后良好,患者可通过门诊治疗恢复,无并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
DEODAR (CEDRUS DEODARA (ROXB.) LOUD.): THERAPEUTIC USES AND PHARMACOLOGICAL STUDIES-A REVIEW ETHNOBOTANY, PHARMACOLOGICAL APPLICATION, PHYTOCHEMISTRY AND THERAPEUTIC POTENTIAL OF BLACK PEPPER (PIPER NIGRUM L.): AN UPDATED REVIEW AN OVERVIEW ON THE PHARMACOLOGICAL ACTIVITIES OF Myrtus Communis L. UNANI ASPECT OF HEALTH AND DISEASES UNANI ASPECT OF HEALTH AND DISEASES
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1